Toward Personalized Treatment of Advanced Biliary Tract Cancers - Daniel M Geynisman - Discovery Med
A number of trials examined the use of cetuximab, a chimeric anti-EGFR monoclonal antibody, in aBTC. A case report demonstrated the feasibility of combining gemcitabine with cetuximab (Sprinzl et al., 2006). This led to a 9-patient trial of cetuximab with...